← Eichor
Study identifier: NCT02677064 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Condition: Acute Leukemia · Newly Diagnosed · Relapsed  ·  Sponsor: Memorial Sloan Kettering Cancer Center

PhaseN/A
Planned participants1365
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.

This description comes directly from the study's public registry record.

Talk to the study team

Roni Tamari, MD  ·  ABMTTrials@mskcc.org

Sergio Giralt, MD  ·  ABMTTrials@mskcc.org

Always discuss trial participation with your own doctor first.

Locations (3)

Hartford Healthcare Cancer Institute @ Hartford HospitalHartford, Connecticut, United StatesRecruiting
Memorial Sloan Kettering Cancer CenterNew York, New York, United StatesRecruiting
Lehigh Valley Health NetworkAllentown, Pennsylvania, United StatesActive Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02677064